Drug and Therapeutics Bulletin 1999;37:30-32; doi:10.1136/dtb.1999.37430
Copyright © 1999 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Ursodeoxycholic acid for primary biliary cirrhosis

Relevant BNF section: 1.9.1

Primary biliary cirrhosis is a progressive chronic liver disease estimated to affect up to 1 in 4000 people in the UK.1 Patients with end-stage disease or an associated poor quality of life commonly need a liver transplant. Traditionally, drugs have offered little help as their benefits are modest and their unwanted effects unacceptable. Recently, the bile acid ursodeoxycholic acid has been used to treat primary biliary cirrhosis . Here we discuss the place of such therapy.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1999 BMJ Publishing Group Ltd.